Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2025-12-25 @ 8:17 PM
NCT ID:
NCT01582269
Group ID:
EG001
Title:
Arm B: Galunisertib + Lomustine
Description:
* Participants received Galunisertib 300 mg orally BID for 14 days, followed by 14 days of rest in a 28-day cycle.
* Participants received a first dose of Lomustine at 100 mg/m² administered orally. Thereafter, starting with the second dose, Lomustine was administered orally once every 6 weeks at 100-130 mg/m², at the discretion of the investigator.
* Treatment continued until disease progression, death, or discontinuation criteria were met.
Deaths Number Affected:
75
Deaths Number At Risk:
None
Serious Number Affected:
31
Serious Number At Risk:
78
Other Number Affected:
69
Other Number At Risk:
78
Study:
NCT01582269
Results Section:
NCT01582269
Adverse Events Module:
NCT01582269